nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—scrotum—colon cancer	0.0842	0.492	CbGeAlD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0182	0.0751	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0138	0.057	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—colon cancer	0.0111	0.0459	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CHST4—colon cancer	0.00793	0.0328	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.00785	0.0325	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.00676	0.028	CbGpPWpGaD
Cyproterone acetate—AR—epithelium—colon cancer	0.00667	0.039	CbGeAlD
Cyproterone acetate—AR—smooth muscle tissue—colon cancer	0.00643	0.0375	CbGeAlD
Cyproterone acetate—AR—renal system—colon cancer	0.00619	0.0361	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—HNF4A—colon cancer	0.00608	0.0251	CbGpPWpGaD
Cyproterone acetate—NR3C1—embryo—colon cancer	0.00592	0.0346	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—AXIN2—colon cancer	0.00568	0.0235	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—MLH1—colon cancer	0.00564	0.0233	CbGpPWpGaD
Cyproterone acetate—AR—lymphoid tissue—colon cancer	0.00514	0.03	CbGeAlD
Cyproterone acetate—AR—digestive system—colon cancer	0.00508	0.0296	CbGeAlD
Cyproterone acetate—NR3C1—epithelium—colon cancer	0.00483	0.0282	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0048	0.0199	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00476	0.0197	CbGpPWpGaD
Cyproterone acetate—NR3C1—smooth muscle tissue—colon cancer	0.00466	0.0272	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptors—HNF4A—colon cancer	0.00461	0.0191	CbGpPWpGaD
Cyproterone acetate—AR—vagina—colon cancer	0.00448	0.0262	CbGeAlD
Cyproterone acetate—NR3C1—renal system—colon cancer	0.00448	0.0262	CbGeAlD
Cyproterone acetate—CYP19A1—liver—colon cancer	0.00427	0.0249	CbGeAlD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.0041	0.017	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00409	0.0169	CbGpPWpGaD
Cyproterone acetate—AR—liver—colon cancer	0.00378	0.0221	CbGeAlD
Cyproterone acetate—NR3C1—lymphoid tissue—colon cancer	0.00372	0.0217	CbGeAlD
Cyproterone acetate—NR3C1—digestive system—colon cancer	0.00368	0.0215	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00364	0.0151	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CHST5—colon cancer	0.00364	0.0151	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—colon cancer	0.00339	0.014	CbGpPWpGaD
Cyproterone acetate—NR3C1—bone marrow—colon cancer	0.00339	0.0198	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.00332	0.0137	CbGpPWpGaD
Cyproterone acetate—CYP19A1—lymph node—colon cancer	0.00327	0.0191	CbGeAlD
Cyproterone acetate—NR3C1—vagina—colon cancer	0.00325	0.019	CbGeAlD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—colon cancer	0.0031	0.0128	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00291	0.012	CbGpPWpGaD
Cyproterone acetate—AR—lymph node—colon cancer	0.0029	0.0169	CbGeAlD
Cyproterone acetate—NR3C1—liver—colon cancer	0.00274	0.016	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—colon cancer	0.00264	0.0109	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00259	0.0107	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.00252	0.0104	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00223	0.00922	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.0021	0.00869	CbGpPWpGaD
Cyproterone acetate—NR3C1—lymph node—colon cancer	0.0021	0.0123	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00208	0.00862	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—colon cancer	0.002	0.00828	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00198	0.0082	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—SRC—colon cancer	0.00198	0.00817	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—SRC—colon cancer	0.0019	0.00785	CbGpPWpGaD
Cyproterone acetate—Sweating—Irinotecan—colon cancer	0.00188	0.00321	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Fluorouracil—colon cancer	0.00186	0.00317	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Fluorouracil—colon cancer	0.00185	0.00315	CcSEcCtD
Cyproterone acetate—Libido decreased—Capecitabine—colon cancer	0.00184	0.00314	CcSEcCtD
Cyproterone acetate—Hot flush—Capecitabine—colon cancer	0.00183	0.00311	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Capecitabine—colon cancer	0.00181	0.00309	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Capecitabine—colon cancer	0.00181	0.00309	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00181	0.00748	CbGpPWpGaD
Cyproterone acetate—Connective tissue disorder—Vincristine—colon cancer	0.00178	0.00304	CcSEcCtD
Cyproterone acetate—Haemoglobin—Irinotecan—colon cancer	0.00177	0.00303	CcSEcCtD
Cyproterone acetate—Haemorrhage—Irinotecan—colon cancer	0.00176	0.00301	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Methotrexate—colon cancer	0.00175	0.00299	CcSEcCtD
Cyproterone acetate—Cardiac failure—Capecitabine—colon cancer	0.00175	0.00298	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Capecitabine—colon cancer	0.00174	0.00297	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Irinotecan—colon cancer	0.00173	0.00296	CcSEcCtD
Cyproterone acetate—Visual impairment—Irinotecan—colon cancer	0.0017	0.0029	CcSEcCtD
Cyproterone acetate—Haemoglobin—Fluorouracil—colon cancer	0.0017	0.0029	CcSEcCtD
Cyproterone acetate—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00169	0.00289	CcSEcCtD
Cyproterone acetate—Haemorrhage—Fluorouracil—colon cancer	0.00169	0.00288	CcSEcCtD
Cyproterone acetate—Migraine—Capecitabine—colon cancer	0.00168	0.00287	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00167	0.00691	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Vincristine—colon cancer	0.00164	0.0028	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Vincristine—colon cancer	0.00163	0.00279	CcSEcCtD
Cyproterone acetate—Mood swings—Capecitabine—colon cancer	0.00162	0.00276	CcSEcCtD
Cyproterone acetate—Alopecia—Vincristine—colon cancer	0.0016	0.00273	CcSEcCtD
Cyproterone acetate—Angiopathy—Irinotecan—colon cancer	0.0016	0.00273	CcSEcCtD
Cyproterone acetate—Coma—Methotrexate—colon cancer	0.0016	0.00273	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Capecitabine—colon cancer	0.0016	0.00273	CcSEcCtD
Cyproterone acetate—Immune system disorder—Irinotecan—colon cancer	0.00159	0.00272	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Irinotecan—colon cancer	0.00159	0.00271	CcSEcCtD
Cyproterone acetate—Mental disorder—Vincristine—colon cancer	0.00159	0.00271	CcSEcCtD
Cyproterone acetate—Chills—Irinotecan—colon cancer	0.00158	0.0027	CcSEcCtD
Cyproterone acetate—Neoplasm—Methotrexate—colon cancer	0.00158	0.0027	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00158	0.00654	CbGpPWpGaD
Cyproterone acetate—Liver function test abnormal—Capecitabine—colon cancer	0.00158	0.00269	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Methotrexate—colon cancer	0.00157	0.00267	CcSEcCtD
Cyproterone acetate—Alopecia—Irinotecan—colon cancer	0.00156	0.00266	CcSEcCtD
Cyproterone acetate—Breast disorder—Capecitabine—colon cancer	0.00154	0.00263	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00154	0.00262	CcSEcCtD
Cyproterone acetate—AR—FOXA1 transcription factor network—EP300—colon cancer	0.00154	0.00635	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—colon cancer	0.00151	0.00623	CbGpPWpGaD
Cyproterone acetate—Muscular weakness—Capecitabine—colon cancer	0.00151	0.00257	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00151	0.00257	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—colon cancer	0.0015	0.00622	CbGpPWpGaD
Cyproterone acetate—Alopecia—Fluorouracil—colon cancer	0.00149	0.00255	CcSEcCtD
Cyproterone acetate—Asthma—Capecitabine—colon cancer	0.00148	0.00252	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—BAX—colon cancer	0.00147	0.00608	CbGpPWpGaD
Cyproterone acetate—Thrombophlebitis—Methotrexate—colon cancer	0.00147	0.0025	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Methotrexate—colon cancer	0.00146	0.00249	CcSEcCtD
Cyproterone acetate—Anaemia—Vincristine—colon cancer	0.00146	0.00249	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—EP300—colon cancer	0.00146	0.00602	CbGpPWpGaD
Cyproterone acetate—Agitation—Vincristine—colon cancer	0.00145	0.00247	CcSEcCtD
Cyproterone acetate—Sweating increased—Capecitabine—colon cancer	0.00144	0.00245	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Irinotecan—colon cancer	0.00143	0.00243	CcSEcCtD
Cyproterone acetate—Anaemia—Irinotecan—colon cancer	0.00142	0.00242	CcSEcCtD
Cyproterone acetate—Hepatic failure—Methotrexate—colon cancer	0.00141	0.00241	CcSEcCtD
Cyproterone acetate—Leukopenia—Vincristine—colon cancer	0.00141	0.00241	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—HRAS—colon cancer	0.00139	0.00575	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—colon cancer	0.00139	0.00574	CbGpPWpGaD
Cyproterone acetate—Malaise—Irinotecan—colon cancer	0.00139	0.00236	CcSEcCtD
Cyproterone acetate—Syncope—Irinotecan—colon cancer	0.00138	0.00235	CcSEcCtD
Cyproterone acetate—Leukopenia—Irinotecan—colon cancer	0.00138	0.00235	CcSEcCtD
Cyproterone acetate—Anaemia—Fluorouracil—colon cancer	0.00136	0.00232	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Irinotecan—colon cancer	0.00135	0.0023	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Methotrexate—colon cancer	0.00135	0.0023	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Capecitabine—colon cancer	0.00135	0.0023	CcSEcCtD
Cyproterone acetate—Weight increased—Capecitabine—colon cancer	0.00134	0.00229	CcSEcCtD
Cyproterone acetate—Cough—Irinotecan—colon cancer	0.00134	0.00229	CcSEcCtD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.00134	0.00553	CbGpPWpGaD
Cyproterone acetate—Weight decreased—Capecitabine—colon cancer	0.00134	0.00228	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00133	0.00552	CbGpPWpGaD
Cyproterone acetate—Hyperglycaemia—Capecitabine—colon cancer	0.00133	0.00227	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—EP300—colon cancer	0.00132	0.00547	CbGpPWpGaD
Cyproterone acetate—Leukopenia—Fluorouracil—colon cancer	0.00132	0.00225	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APC—colon cancer	0.0013	0.00539	CbGpPWpGaD
Cyproterone acetate—Acute coronary syndrome—Capecitabine—colon cancer	0.0013	0.00221	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Methotrexate—colon cancer	0.0013	0.00221	CcSEcCtD
Cyproterone acetate—Renal failure—Capecitabine—colon cancer	0.00129	0.00221	CcSEcCtD
Cyproterone acetate—Discomfort—Irinotecan—colon cancer	0.00129	0.0022	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Capecitabine—colon cancer	0.00129	0.0022	CcSEcCtD
Cyproterone acetate—Oedema—Vincristine—colon cancer	0.00129	0.0022	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—SRC—colon cancer	0.00129	0.00532	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CCND1—colon cancer	0.00128	0.00531	CbGpPWpGaD
Cyproterone acetate—Jaundice—Capecitabine—colon cancer	0.00128	0.00219	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.00127	0.00526	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Vincristine—colon cancer	0.00126	0.00215	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Vincristine—colon cancer	0.00126	0.00215	CcSEcCtD
Cyproterone acetate—Haematuria—Capecitabine—colon cancer	0.00125	0.00214	CcSEcCtD
Cyproterone acetate—Oedema—Irinotecan—colon cancer	0.00125	0.00214	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Vincristine—colon cancer	0.00124	0.00212	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Capecitabine—colon cancer	0.00124	0.00212	CcSEcCtD
Cyproterone acetate—Discomfort—Fluorouracil—colon cancer	0.00124	0.00211	CcSEcCtD
Cyproterone acetate—Shock—Irinotecan—colon cancer	0.00123	0.0021	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Irinotecan—colon cancer	0.00123	0.0021	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Irinotecan—colon cancer	0.00123	0.00209	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.00123	0.00508	CbGpPWpGaD
Cyproterone acetate—Anorexia—Vincristine—colon cancer	0.00123	0.00209	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Irinotecan—colon cancer	0.00121	0.00207	CcSEcCtD
Cyproterone acetate—Mood swings—Methotrexate—colon cancer	0.0012	0.00205	CcSEcCtD
Cyproterone acetate—Hypotension—Vincristine—colon cancer	0.0012	0.00205	CcSEcCtD
Cyproterone acetate—Oedema—Fluorouracil—colon cancer	0.0012	0.00205	CcSEcCtD
Cyproterone acetate—Anorexia—Irinotecan—colon cancer	0.0012	0.00204	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.00119	0.00492	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Capecitabine—colon cancer	0.00119	0.00203	CcSEcCtD
Cyproterone acetate—Haemorrhage—Capecitabine—colon cancer	0.00118	0.00201	CcSEcCtD
Cyproterone acetate—Hepatitis—Capecitabine—colon cancer	0.00118	0.00201	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—colon cancer	0.00118	0.00488	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Fluorouracil—colon cancer	0.00118	0.00201	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Fluorouracil—colon cancer	0.00118	0.00201	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Methotrexate—colon cancer	0.00117	0.002	CcSEcCtD
Cyproterone acetate—Tachycardia—Fluorouracil—colon cancer	0.00117	0.002	CcSEcCtD
Cyproterone acetate—Hypotension—Irinotecan—colon cancer	0.00117	0.002	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Capecitabine—colon cancer	0.00116	0.00198	CcSEcCtD
Cyproterone acetate—Breast disorder—Methotrexate—colon cancer	0.00115	0.00196	CcSEcCtD
Cyproterone acetate—Anorexia—Fluorouracil—colon cancer	0.00114	0.00195	CcSEcCtD
Cyproterone acetate—Visual impairment—Capecitabine—colon cancer	0.00114	0.00194	CcSEcCtD
Cyproterone acetate—Hypotension—Fluorouracil—colon cancer	0.00112	0.00191	CcSEcCtD
Cyproterone acetate—Decreased appetite—Vincristine—colon cancer	0.00112	0.00191	CcSEcCtD
Cyproterone acetate—Dyspnoea—Irinotecan—colon cancer	0.00112	0.00191	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Capecitabine—colon cancer	0.00112	0.0019	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Vincristine—colon cancer	0.00111	0.0019	CcSEcCtD
Cyproterone acetate—Fatigue—Vincristine—colon cancer	0.00111	0.00189	CcSEcCtD
Cyproterone acetate—Eye disorder—Capecitabine—colon cancer	0.0011	0.00188	CcSEcCtD
Cyproterone acetate—Dyspepsia—Irinotecan—colon cancer	0.0011	0.00188	CcSEcCtD
Cyproterone acetate—Constipation—Vincristine—colon cancer	0.0011	0.00188	CcSEcCtD
Cyproterone acetate—Asthma—Methotrexate—colon cancer	0.0011	0.00187	CcSEcCtD
Cyproterone acetate—Decreased appetite—Irinotecan—colon cancer	0.00109	0.00186	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Irinotecan—colon cancer	0.00108	0.00185	CcSEcCtD
Cyproterone acetate—Fatigue—Irinotecan—colon cancer	0.00108	0.00184	CcSEcCtD
Cyproterone acetate—Pancreatitis—Methotrexate—colon cancer	0.00108	0.00184	CcSEcCtD
Cyproterone acetate—Constipation—Irinotecan—colon cancer	0.00107	0.00183	CcSEcCtD
Cyproterone acetate—Angiopathy—Capecitabine—colon cancer	0.00107	0.00183	CcSEcCtD
Cyproterone acetate—Dyspnoea—Fluorouracil—colon cancer	0.00107	0.00183	CcSEcCtD
Cyproterone acetate—Immune system disorder—Capecitabine—colon cancer	0.00107	0.00182	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Capecitabine—colon cancer	0.00106	0.00182	CcSEcCtD
Cyproterone acetate—Chills—Capecitabine—colon cancer	0.00106	0.00181	CcSEcCtD
Cyproterone acetate—Dyspepsia—Fluorouracil—colon cancer	0.00106	0.0018	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Vincristine—colon cancer	0.00105	0.0018	CcSEcCtD
Cyproterone acetate—Decreased appetite—Fluorouracil—colon cancer	0.00104	0.00178	CcSEcCtD
Cyproterone acetate—Alopecia—Capecitabine—colon cancer	0.00104	0.00178	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00104	0.00431	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA7—colon cancer	0.00104	0.00431	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00104	0.00177	CcSEcCtD
Cyproterone acetate—Mental disorder—Capecitabine—colon cancer	0.00103	0.00177	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.00103	0.00428	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Irinotecan—colon cancer	0.00103	0.00176	CcSEcCtD
Cyproterone acetate—Malnutrition—Capecitabine—colon cancer	0.00103	0.00175	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Irinotecan—colon cancer	0.00103	0.00175	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BAX—colon cancer	0.00102	0.00423	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.00102	0.00423	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00102	0.00423	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Vincristine—colon cancer	0.00102	0.00174	CcSEcCtD
Cyproterone acetate—Abdominal pain—Vincristine—colon cancer	0.00102	0.00174	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—colon cancer	0.00101	0.00173	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	0.001	0.00415	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—colon cancer	0.001	0.00171	CcSEcCtD
Cyproterone acetate—Abdominal pain—Irinotecan—colon cancer	0.000991	0.00169	CcSEcCtD
Cyproterone acetate—Body temperature increased—Irinotecan—colon cancer	0.000991	0.00169	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.00099	0.0041	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Fluorouracil—colon cancer	0.00099	0.00169	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000986	0.00408	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	0.000976	0.00404	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—EP300—colon cancer	0.000974	0.00403	CbGpPWpGaD
Cyproterone acetate—Renal failure—Methotrexate—colon cancer	0.000963	0.00164	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Capecitabine—colon cancer	0.000954	0.00163	CcSEcCtD
Cyproterone acetate—Urticaria—Fluorouracil—colon cancer	0.000954	0.00163	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.000952	0.00394	CbGpPWpGaD
Cyproterone acetate—Anaemia—Capecitabine—colon cancer	0.00095	0.00162	CcSEcCtD
Cyproterone acetate—Body temperature increased—Fluorouracil—colon cancer	0.000949	0.00162	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.000949	0.00393	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Vincristine—colon cancer	0.000949	0.00162	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000942	0.0039	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.00094	0.00389	CbGpPWpGaD
Cyproterone acetate—Sweating—Methotrexate—colon cancer	0.000939	0.0016	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—colon cancer	0.000934	0.00159	CcSEcCtD
Cyproterone acetate—Malaise—Capecitabine—colon cancer	0.000927	0.00158	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—colon cancer	0.000926	0.00158	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Irinotecan—colon cancer	0.000924	0.00158	CcSEcCtD
Cyproterone acetate—Asthenia—Vincristine—colon cancer	0.000924	0.00158	CcSEcCtD
Cyproterone acetate—Syncope—Capecitabine—colon cancer	0.000922	0.00157	CcSEcCtD
Cyproterone acetate—Leukopenia—Capecitabine—colon cancer	0.00092	0.00157	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.000918	0.0038	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Capecitabine—colon cancer	0.000904	0.00154	CcSEcCtD
Cyproterone acetate—Asthenia—Irinotecan—colon cancer	0.0009	0.00153	CcSEcCtD
Cyproterone acetate—Cough—Capecitabine—colon cancer	0.000897	0.00153	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Fluorouracil—colon cancer	0.000885	0.00151	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	0.000884	0.00366	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Methotrexate—colon cancer	0.000884	0.00151	CcSEcCtD
Cyproterone acetate—Diarrhoea—Vincristine—colon cancer	0.000881	0.0015	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—colon cancer	0.000879	0.0015	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—colon cancer	0.000879	0.0015	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.000874	0.00361	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	0.000873	0.00361	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000869	0.00148	CcSEcCtD
Cyproterone acetate—Discomfort—Capecitabine—colon cancer	0.000865	0.00148	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000864	0.00357	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Irinotecan—colon cancer	0.000858	0.00146	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000852	0.00352	CbGpPWpGaD
Cyproterone acetate—Dizziness—Vincristine—colon cancer	0.000851	0.00145	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.00085	0.00351	CbGpPWpGaD
Cyproterone acetate—Pruritus—Fluorouracil—colon cancer	0.00085	0.00145	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—colon cancer	0.000847	0.00145	CcSEcCtD
Cyproterone acetate—Oedema—Capecitabine—colon cancer	0.000839	0.00143	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000834	0.00345	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Methotrexate—colon cancer	0.000831	0.00142	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—HNF4A—colon cancer	0.000829	0.00343	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.000829	0.00343	CbGpPWpGaD
Cyproterone acetate—Dizziness—Irinotecan—colon cancer	0.000829	0.00141	CcSEcCtD
Cyproterone acetate—Shock—Capecitabine—colon cancer	0.000826	0.00141	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Capecitabine—colon cancer	0.000823	0.0014	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—colon cancer	0.000822	0.0014	CcSEcCtD
Cyproterone acetate—Diarrhoea—Fluorouracil—colon cancer	0.000822	0.0014	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Capecitabine—colon cancer	0.000822	0.0014	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000821	0.0034	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Capecitabine—colon cancer	0.000819	0.0014	CcSEcCtD
Cyproterone acetate—Vomiting—Vincristine—colon cancer	0.000819	0.0014	CcSEcCtD
Cyproterone acetate—Skin disorder—Capecitabine—colon cancer	0.000815	0.00139	CcSEcCtD
Cyproterone acetate—Rash—Vincristine—colon cancer	0.000812	0.00138	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Capecitabine—colon cancer	0.000811	0.00138	CcSEcCtD
Cyproterone acetate—Dermatitis—Vincristine—colon cancer	0.000811	0.00138	CcSEcCtD
Cyproterone acetate—Headache—Vincristine—colon cancer	0.000807	0.00138	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EP300—colon cancer	0.000803	0.00332	CbGpPWpGaD
Cyproterone acetate—Anorexia—Capecitabine—colon cancer	0.0008	0.00136	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—colon cancer	0.000798	0.00136	CcSEcCtD
Cyproterone acetate—Vomiting—Irinotecan—colon cancer	0.000797	0.00136	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—colon cancer	0.000794	0.00135	CcSEcCtD
Cyproterone acetate—Dizziness—Fluorouracil—colon cancer	0.000794	0.00135	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—colon cancer	0.000792	0.00135	CcSEcCtD
Cyproterone acetate—Rash—Irinotecan—colon cancer	0.000791	0.00135	CcSEcCtD
Cyproterone acetate—Dermatitis—Irinotecan—colon cancer	0.00079	0.00135	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—colon cancer	0.000789	0.00135	CcSEcCtD
Cyproterone acetate—Headache—Irinotecan—colon cancer	0.000785	0.00134	CcSEcCtD
Cyproterone acetate—Hypotension—Capecitabine—colon cancer	0.000784	0.00134	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—colon cancer	0.000777	0.00133	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—colon cancer	0.00077	0.00131	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—colon cancer	0.000765	0.00131	CcSEcCtD
Cyproterone acetate—Nausea—Vincristine—colon cancer	0.000765	0.0013	CcSEcCtD
Cyproterone acetate—Vomiting—Fluorouracil—colon cancer	0.000764	0.0013	CcSEcCtD
Cyproterone acetate—Rash—Fluorouracil—colon cancer	0.000757	0.00129	CcSEcCtD
Cyproterone acetate—Dermatitis—Fluorouracil—colon cancer	0.000756	0.00129	CcSEcCtD
Cyproterone acetate—Headache—Fluorouracil—colon cancer	0.000752	0.00128	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000751	0.00311	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000751	0.00311	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—colon cancer	0.000748	0.00309	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Capecitabine—colon cancer	0.000748	0.00128	CcSEcCtD
Cyproterone acetate—Nausea—Irinotecan—colon cancer	0.000745	0.00127	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.000745	0.00308	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	0.000744	0.00308	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Capecitabine—colon cancer	0.000739	0.00126	CcSEcCtD
Cyproterone acetate—Megestrol acetate—ABCB1—colon cancer	0.000734	1	CrCbGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000733	0.00303	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Capecitabine—colon cancer	0.000729	0.00124	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Capecitabine—colon cancer	0.000724	0.00124	CcSEcCtD
Cyproterone acetate—Fatigue—Capecitabine—colon cancer	0.000724	0.00123	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000718	0.00297	CbGpPWpGaD
Cyproterone acetate—Constipation—Capecitabine—colon cancer	0.000718	0.00122	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000715	0.00296	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	0.000715	0.00296	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	0.000714	0.00295	CbGpPWpGaD
Cyproterone acetate—Nausea—Fluorouracil—colon cancer	0.000713	0.00122	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—colon cancer	0.00071	0.00121	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	0.000708	0.00293	CbGpPWpGaD
Cyproterone acetate—Anaemia—Methotrexate—colon cancer	0.000707	0.00121	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000704	0.00291	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—colon cancer	0.0007	0.0029	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	0.000698	0.00289	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Capecitabine—colon cancer	0.000692	0.00118	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—colon cancer	0.00069	0.00118	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Capecitabine—colon cancer	0.000686	0.00117	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—colon cancer	0.000685	0.00117	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—colon cancer	0.000668	0.00114	CcSEcCtD
Cyproterone acetate—Urticaria—Capecitabine—colon cancer	0.000667	0.00114	CcSEcCtD
Cyproterone acetate—Body temperature increased—Capecitabine—colon cancer	0.000663	0.00113	CcSEcCtD
Cyproterone acetate—Abdominal pain—Capecitabine—colon cancer	0.000663	0.00113	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000647	0.0011	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—colon cancer	0.000644	0.0011	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000639	0.00264	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ODC1—colon cancer	0.000631	0.00261	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CHST5—colon cancer	0.000631	0.00261	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	0.000629	0.0026	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000623	0.00258	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000622	0.00257	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000622	0.00257	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Capecitabine—colon cancer	0.000618	0.00105	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000616	0.00255	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Methotrexate—colon cancer	0.000613	0.00104	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—colon cancer	0.000612	0.00104	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—colon cancer	0.000607	0.00104	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—colon cancer	0.000604	0.00103	CcSEcCtD
Cyproterone acetate—Asthenia—Capecitabine—colon cancer	0.000602	0.00103	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.0006	0.00248	CbGpPWpGaD
Cyproterone acetate—Anorexia—Methotrexate—colon cancer	0.000595	0.00102	CcSEcCtD
Cyproterone acetate—Pruritus—Capecitabine—colon cancer	0.000594	0.00101	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—colon cancer	0.000584	0.000996	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—colon cancer	0.000575	0.00238	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Capecitabine—colon cancer	0.000574	0.000979	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000572	0.00237	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00057	0.00236	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000569	0.00235	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—colon cancer	0.000558	0.00231	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Methotrexate—colon cancer	0.000557	0.00095	CcSEcCtD
Cyproterone acetate—Dizziness—Capecitabine—colon cancer	0.000555	0.000947	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—colon cancer	0.00055	0.000938	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.00055	0.00227	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Methotrexate—colon cancer	0.000543	0.000926	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000542	0.00224	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000539	0.00092	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—colon cancer	0.000539	0.000919	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000535	0.00221	CbGpPWpGaD
Cyproterone acetate—Vomiting—Capecitabine—colon cancer	0.000534	0.00091	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.00053	0.00219	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000529	0.00219	CbGpPWpGaD
Cyproterone acetate—Rash—Capecitabine—colon cancer	0.000529	0.000903	CcSEcCtD
Cyproterone acetate—Dermatitis—Capecitabine—colon cancer	0.000529	0.000902	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000528	0.00218	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—colon cancer	0.000528	0.00218	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—colon cancer	0.000527	0.00218	CbGpPWpGaD
Cyproterone acetate—Headache—Capecitabine—colon cancer	0.000526	0.000897	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000515	0.00213	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Methotrexate—colon cancer	0.000515	0.000878	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—colon cancer	0.000514	0.00213	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—colon cancer	0.000511	0.000871	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.00051	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	0.000506	0.00209	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000499	0.00206	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000498	0.00206	CbGpPWpGaD
Cyproterone acetate—Nausea—Capecitabine—colon cancer	0.000498	0.00085	CcSEcCtD
Cyproterone acetate—Urticaria—Methotrexate—colon cancer	0.000496	0.000847	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—colon cancer	0.000494	0.000842	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—colon cancer	0.000494	0.000842	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000493	0.00204	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000488	0.00202	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000474	0.00196	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000472	0.00195	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000466	0.00193	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000461	0.00191	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000461	0.00191	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Methotrexate—colon cancer	0.00046	0.000785	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000455	0.00188	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000449	0.00186	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—colon cancer	0.000448	0.000765	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—colon cancer	0.000442	0.000754	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000432	0.00179	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000429	0.00178	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	0.000428	0.00177	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Methotrexate—colon cancer	0.000427	0.000729	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—colon cancer	0.000426	0.00176	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	0.000423	0.00175	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.00042	0.00174	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000413	0.00171	CbGpPWpGaD
Cyproterone acetate—Dizziness—Methotrexate—colon cancer	0.000413	0.000705	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000412	0.00171	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.00041	0.00169	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000404	0.00167	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000401	0.00166	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HNF4A—colon cancer	0.000399	0.00165	CbGpPWpGaD
Cyproterone acetate—Vomiting—Methotrexate—colon cancer	0.000397	0.000678	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000397	0.00164	CbGpPWpGaD
Cyproterone acetate—Rash—Methotrexate—colon cancer	0.000394	0.000672	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—colon cancer	0.000394	0.000671	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—colon cancer	0.000391	0.000668	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000382	0.00158	CbGpPWpGaD
Cyproterone acetate—Nausea—Methotrexate—colon cancer	0.000371	0.000633	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—colon cancer	0.00036	0.00149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000352	0.00146	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000351	0.00145	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000346	0.00143	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000339	0.0014	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HNF4A—colon cancer	0.000303	0.00125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000298	0.00123	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000287	0.00119	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	0.000273	0.00113	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.00026	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—colon cancer	0.000205	0.000849	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000205	0.000848	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—colon cancer	0.000173	0.000717	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.00017	0.000705	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—colon cancer	0.000167	0.00069	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMS—colon cancer	0.000164	0.000677	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—colon cancer	0.000156	0.000644	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—colon cancer	0.000132	0.000544	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000126	0.000521	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—colon cancer	0.000116	0.00048	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—colon cancer	9.88e-05	0.000409	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—colon cancer	9.13e-05	0.000377	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—colon cancer	7.59e-05	0.000314	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—colon cancer	7.5e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—colon cancer	6.86e-05	0.000284	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—colon cancer	5.61e-05	0.000232	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—colon cancer	5.2e-05	0.000215	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—colon cancer	4.59e-05	0.00019	CbGpPWpGaD
